Psoriasis is a common chronic, recurrent, inflammatory, and systemic disease mediated by the immune system. According to the Guideline for the Diagnosis and Treatment of Psoriasis in China (2023 ...

If topical medications haven’t been strong enough to control your psoriasis, your dermatologist may recommend a biologic, a type of drug that targets the part of the immune system responsible for ...

Spinal injections of a common anesthetic may help clear the inflammatory skin condition psoriasis, a small pilot study suggests. The study involved four patients with severe psoriasis, and researchers ...

NEW YORK (Reuters Health) - Injections of a protein called interleukin-4 (IL-4) seem equal to the best therapy now available for relieving symptoms of the chronic skin condition psoriasis, the results ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Picankibart is a recombinant anti-interleukin 23p19 ...

By Dengyuemed International Business Department  November 28 — The National Medical Products Administration (NMPA) has approved the marketing of picankibart injection, an innovative IL-23p19–targeting ...

The webinar will be broadcast via Zoom. Interested participants can register using the following LINK. The discussion will provide an in-depth exploration of the plaque psoriasis landscape, current ...

Innovent Biologics ( ($HK:1801) ) has provided an announcement. Innovent Biologics has announced that its new drug, PECONDLE® (picankibart ...

The latest update is out from Shanghai Junshi Biosciences Co., Ltd. Class H ( ($HK:1877) ). Shanghai Junshi Biosciences Co., Ltd. announced the ...

Sun Pharma launches Ilumya (Tildrakizumab) in India, expanding its specialty medicines portfolio and bringing advanced ...

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, ...